Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monophasic action potential symposium. I. Introduction

M R Franz1

  • 1Georgetown University Medical Center, Washington, DC.

Progress in Cardiovascular Diseases
|May 1, 1991
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing.

Progress in biophysics and molecular biology·2011
Same author

Circadian variation of arrhythmic events, electrophysiological properties, and the autonomic nervous system.

European heart journal·2002
Same author

Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness.

Journal of cardiovascular electrophysiology·2002
Same author

The repolarization-excitability relationship in the human right atrium is unaffected by cycle length, recording site and prior arrhythmias.

Journal of the American College of Cardiology·2001
Same author

Magnetism: the last resort?

Journal of cardiovascular electrophysiology·2001
Same author

Tarantula peptide inhibits atrial fibrillation.

Nature·2001
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
Same journal

Circulating microRNA signatures associated with atrial remodeling in endurance athletes with PAFIYAMA syndrome: A case-control study.

Progress in cardiovascular diseases·2026
See all related articles